Digital Health Landscape 2015: Top 100 Influencers & Brands
Onalytica B2B
MARCH 18, 2015
The FDA (Food and Drug Administration) recently approved the marketing of consumer genetic testing company 23andMe’s test for Bloom Syndrome , which allows for risk-based family planning. This is DTC (direct-to-consumer), which means it doesn’t require a doctor’s order for the consumer to be better informed of their health.
Let's personalize your content